NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

The 10Q for September 30, 2015 lists $611 million as the "accumulated deficit" for Northwest. That is less than I thought.

http://www.sec.gov/Archives/edgar/data/1072379/000114420415063856/v423331_10q.htm

This recent New York Times article claims that the typical cost to put a drug to market is $2.6B. If Northwest is nearly done with getting DCVax-L to market then where's the beef?

http://www.nytimes.com/2014/11/19/upshot/calculating-the-real-costs-of-developing-a-new-drug.html?_r=0